Triple-negative breast cancer (TNBC) is the most aggressive subtype of breast cancer that is characterized by a deficiency in the estrogen receptor (ER), progesterone receptor (PR), and human epidermal growth factor receptor 2 (HER2) [4]. This evidence concerns the gene PGR and breast carcinoma.